Stocks›Healthcare›QDEL

QDEL

Quidelortho Corp

NasdaqResearch view

Quidelortho Corp operates in the In Vitro & In Vivo Diagnostic Substances industry.

$12.57+3.54%

Oct 6 close · 1D EOD · Databento

HealthcareIn Vitro & In Vivo Diagnostic SubstancesSmall-capSEC EDGAR FY 2025-12-28

What happened

Daily closes · dots are Wire stories

What’s next

Expected around early November, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 5, 2025 and Nov 7, 2024, after the close.

Last report

Aug 6, 2026−24.72%

after the close

Last 4, next close

median 19.95% either way

up 0 of 4

Every report since 2023 →Earnings calendar →

DateEventSourceNext close

Aug 6Earnings release, after the close · 8-KSEC EDGARSEC EDGAR ↗−24.72%

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

What happened · big days

19 big days in a year, and what we hold on each

A big day is a close more than 8.48% from the one before, three times QDEL’s median day (2.83%). On 0 of the 19, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.

every other trading daya big day, numbered in the list below±8.48%Hover a bar for its day. Click a big day to open it.

Shaded: since our stories began, Jun 10. Tap a bar for its day.

#DayQDELWhat we hold that dayGroup (median of 4) · each

1 Nov 6, 2025−22.32%
Resultsgroup −2.8%, did not move with it
1Nov 6, 2025−22.32%
ResultsFirst close after the Nov 5 results filing
−2.8% did not move with itLNTH −6.2 · NEOG −3.7 · CLDX −2.0 · IDXX −0.9
2 Nov 11, 2025+10.95%
Before our storiesgroup +4.0%, did not move with it
2Nov 11, 2025+10.95%
Before our stories
+4.0% did not move with itCLDX +7.5 · LNTH +5.3 · NEOG +2.7 · IDXX +0.4
3 Nov 21, 2025+14.27%
Before our storiesgroup +4.7%, did not move with it
3Nov 21, 2025+14.27%
Before our stories
+4.7% did not move with itNEOG +5.7 · IDXX +5.3 · LNTH +4.2 · CLDX +3.4
4 Nov 24, 2025+9.16%
Before our storiesgroup +2.0%, did not move with it
4Nov 24, 2025+9.16%
Before our stories
+2.0% did not move with itIDXX +3.6 · NEOG +2.5 · CLDX +1.5 · LNTH +1.2
5 Jan 21, 2026−10.11%
Before our storiesgroup +2.8%, did not move with it
5Jan 21, 2026−10.11%
Before our stories
+2.8% did not move with itLNTH +0.8 · IDXX +1.5 · CLDX +4.1 · NEOG +5.6
6 Feb 12, 2026−17.59%
Resultsgroup −2.0%, did not move with it
6Feb 12, 2026−17.59%
ResultsFirst close after the Feb 11 results filing
−2.0% did not move with itIDXX −4.9 · CLDX −4.2 · NEOG +0.3 · LNTH +2.1
7 Mar 18, 2026−10.93%
Before our storiesgroup −2.7%, did not move with it
7Mar 18, 2026−10.93%
Before our stories
−2.7% did not move with itNEOG −4.4 · CLDX −3.7 · IDXX −1.7 · LNTH −0.3
8 Mar 23, 2026+8.60%
Before our storiesgroup +1.6%, did not move with it
8Mar 23, 2026+8.60%
Before our stories
+1.6% did not move with itNEOG +5.7 · CLDX +2.9 · IDXX +0.2 · LNTH −0.9
9 Apr 13, 2026+16.10%
Before our storiesgroup +1.2%, did not move with it
9Apr 13, 2026+16.10%
Before our stories
+1.2% did not move with itIDXX +1.9 · LNTH +1.3 · CLDX +1.1 · NEOG −3.0
10 Apr 16, 2026−27.47%
Before our storiesgroup −0.9%, did not move with it
10Apr 16, 2026−27.47%
Before our stories
−0.9% did not move with itNEOG −1.9 · IDXX −1.9 · CLDX −0.0 · LNTH −0.0
11 May 12, 2026+11.65%
Before our storiesgroup −0.1%, did not move with it
11May 12, 2026+11.65%
Before our stories
−0.1% did not move with itLNTH +2.3 · IDXX +0.4 · NEOG −0.5 · CLDX −0.9
12 May 15, 2026−9.39%
Before our storiesgroup −2.9%, did not move with it
12May 15, 2026−9.39%
Before our stories
−2.9% did not move with itCLDX −3.4 · LNTH −2.9 · NEOG −2.9 · IDXX −0.8
13 Jun 4, 2026+12.50%
Before our storiesgroup +1.6%, did not move with it
13Jun 4, 2026+12.50%
Before our stories
+1.6% did not move with itNEOG +3.5 · LNTH +2.6 · IDXX +0.7 · CLDX +0.5
14 Jun 22, 2026−9.51%
Nothing on QDELgroup −0.3%, did not move with it
14Jun 22, 2026−9.51%
Nothing on QDELNo QDEL story, brief or results filing in our record that day
−0.3% did not move with itNEOG −4.2 · IDXX −2.9 · LNTH +2.3 · CLDX +3.0
15 Jun 25, 2026+10.73%
Nothing on QDELgroup +2.3%, did not move with it
15Jun 25, 2026+10.73%
Nothing on QDELNo QDEL story, brief or results filing in our record that day
+2.3% did not move with itLNTH +4.0 · NEOG +3.6 · IDXX +1.1 · CLDX +0.9
16 Jun 29, 2026+32.20%
Nothing on QDELgroup −1.5%, did not move with it
16Jun 29, 2026+32.20%
Nothing on QDELNo QDEL story, brief or results filing in our record that day
−1.5% did not move with itCLDX +6.2 · LNTH −0.2 · IDXX −2.8 · NEOG −5.0
17 Aug 7, 2026−24.72%
Resultsgroup +0.1%, did not move with it
17Aug 7, 2026−24.72%
ResultsFirst close after the Aug 6 results filing
+0.1% did not move with itIDXX −0.6 · LNTH −0.1 · CLDX +0.4 · NEOG +1.5
18 Aug 10, 2026+11.93%
Nothing on QDELgroup +0.8%, did not move with it
18Aug 10, 2026+11.93%
Nothing on QDELNo QDEL story, brief or results filing in our record that day
+0.8% did not move with itCLDX +3.0 · IDXX +1.6 · LNTH +0.0 · NEOG −0.6
19 Oct 5, 2026+12.72%
Nothing on QDELgroup +2.3%, did not move with it
19Oct 5, 2026+12.72%
Nothing on QDELNo QDEL story, brief or results filing in our record that day
+2.3% did not move with itNEOG +7.1 · CLDX +3.0 · IDXX +1.7 · LNTH +0.2

A story on the same day is not a cause, and a group move is not proof either. Group: the median of IDXX, LNTH, NEOG and CLDX that day, the largest companies in QDEL’s SEC industry; “moved with QDEL” means the same direction and at least half the size.

What’s next · results

Before the next report: what the first day after the last four did

Six trading days after each results filing (SEC 8-K, Item 2.02). QDEL reports after the close, so day 1 is the next close. Each time, day 6 ended on the same side as day 1.

Reported Nov 5, 2025

day 1−22.32%day 6−18.96%

Reported Feb 11, 2026

day 1−17.59%day 6−21.94%

Reported May 5, 2026

day 1−6.00%day 6−5.23%

Reported Aug 6, 2026

day 1−24.72%day 6−12.38%

Next report: expected early NovemberEstimated from the dates of its last four results filings. Not announced. Since the Aug 6 report: −25.61%. Four reports is a small sample.

Every report since 2023 →

Each line is QDEL’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.

The numbers · FY2025, filed

SEC EDGAR

Market cap$739M

Revenue$2.7B−1.90%

Net income$-1.1B

EPS, diluted$-16.69+45.40%

Operating margin-33.7%

Return on equity7349.4%

Debt / equity-186.75

All filed figures

Snapshot

SEC EDGAR · FY 2025-12-28

SectorHealthcare

Market Cap$738.6M

Enterprise Value$3.4B

Income$-1.1B

Sales$2.7B

Book/sh$-0.22

Cash/sh$2.48

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio0.90

Current Ratio1.50

Debt/Eq-186.75

EPS (ttm)$-16.69

EPS this Y45.4%

EPS past 3/5Y—

Sales past 3/5Y-5.8%

EPS Y/Y TTM45.4%

Sales Y/Y TTM-1.9%

Shs Outstand68.58M

ROA-19.6%

ROE7349.4%

ROIC-34.9%

Gross Margin—

Oper. Margin-33.7%

Profit Margin-41.5%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$1.7B

FY22

$3.3B

FY23

$3.0B

FY23

$2.8B

FY24

$2.7B

FY25

Operating leverage — margins

GrossOperatingNet

Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2022	FY2023	FY2023	FY2024	FY2025
Revenue	$1.7B	$3.3B	$3.0B	$2.8B	$2.7B
Gross Profit	—	—	—	—	—
Operating Income	$906.0M	$843.7M	$139.1M	$-2.0B	$-919.2M
Net Income	$704.2M	$548.7M	$-10.1M	$-2.1B	$-1.1B
Diluted EPS	$16.43	$9.56	$-0.15	$-30.54	$-16.69
Operating Cash Flow	$805.9M	$885.3M	$280.2M	$83.0M	$105.2M
Free Cash Flow	$513.1M	$744.4M	$70.9M	$-112.1M	$-83.0M

Same industry

QDEL against four same-industry peers, a year at 100

QDEL is down 54.0% in a year. Neogen is up 2.2 times, Lantheus Holdings is up 87.1%, Celldex Therapeutics 21.7% and Idexx Laboratories is down 14.5%. All four did more. Weekly closes, Oct 10, 2025 = 100, on a log scale so a 2.2-fold rise and a 54.0% fall both read honestly.

Share this chart

QDEL −54.0%. Neogen ×2.2, Lantheus Holdings +87.1%, Celldex Therapeutics +21.7%, Idexx Laboratories −14.5%. Weekly closes, Oct 10, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in QDEL’s SEC industry (In Vitro & In Vivo Diagnostic Substances) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

Same industry

In the screener →

IDXX$40.8B LNTH$6.5B NEOG$2.6B CLDX$2.5B NTLA$1.7B TKNO$483M MYGN$434M NNNN$242M

Build basket with QDEL Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.